Medicinal Herb Research: Serum Pharmacological Method and Plasma Pharmacological Method

Ge Jin-wen, Dongsheng Wang, Rong He, Huibin Zhu, Yuhong Wang, Shilin HeBiological 2010 · DOI

Abstract

The serum pharmacological method has long been the standard for evaluating medicinal herbs ex vivo. However, the process of preparing test serum is intricate and involves biochemical reactions that do not occur in a healthy living body. This "clotting storm"—including proteolytic cascades, platelet activation, and the release of various enzymes—can significantly alter the herbal components being studied. This paper reviews the evidence suggesting that the plasma pharmacological method provides a more accurate reflection of the in vivo state. While serum remains useful when anticoagulants interfere with specific assays, plasma is generally a superior medium for capturing the true physiological and pharmacological profile of absorbed medicinal herbs.

The Problem with the Serum Pharmacological Method

When studying medicinal herbs, researchers must account for how the body metabolizes compounds. Simply adding raw extracts to cell cultures (in vitro) ignores the transformative effects of digestion and circulation. To bridge this gap, the "serum pharmacological method" was developed: an animal is fed the herb, its blood is collected and allowed to clot, and the resulting serum is applied to experimental models.

However, this method introduces a significant biological artifact. Serum is a product of blood coagulation, a violent biochemical process involving the activation of the complement, kinin, and fibrinolysis systems. As shown in the process flow below, these reactions can degrade herbal metabolites or physically trap them within fibrin clots, leading to results that may not represent the herb's actual behavior in a living organism.

Figure 1: Comparison of preparation processes for standby plasma and standby serum, highlighting the biochemical changes induced during coagulation.

The "Clotting Storm" and Metabolite Interference

The transition from blood to serum involves a massive cascade of serine proteases (such as FIIa, FXa, and FIXa) and the release of lysosomal enzymes from activated platelets and leukocytes. These endogenous factors can have two major negative effects on research validity:

  1. Chemical Alteration: Herbal components can be cleaved or modified by the proteases activated during clotting.
  2. Physical Loss: Fibrin clots can absorb and sequester herbal metabolites, leading to "false negatives" where the herb appears less potent than it truly is in vivo.

Furthermore, the serum environment is enriched with growth factors and cytokines released during clotting. In some cases, these endogenous signaling molecules can completely mask or even reverse the herb's intended effect. For instance, in studies of the herb Jiexinkang, the plasma method correctly identified inhibitory effects on leukemia cells, whereas the serum method showed promoted growth due to the interference of clotting-related growth factors.

Analytical Evidence of Divergence

Modern analytical tools like HPLC-MS and PDA chromatography have confirmed that the chemical "fingerprints" of plasma and serum are distinct. Proteomic analysis has revealed that over 40% of peptides found in serum are specific to the clotting process and are absent in circulating plasma.

Figure 6: A representative PDA MaxPlot chromatogram illustrating the high complexity of blood-derived samples used in pharmacological fingerprinting.

In studies of Tailaofang, polar components were found to be significantly lower in serum than in plasma, suggesting substantial loss during the clotting process. Similarly, studies on Danshan and Wurenchun demonstrated that plasma samples exhibited more potent protective or proangiogenic effects than their serum counterparts, indicating that the plasma method is a more sensitive and accurate tool for bioactivity assessment.

Limitations and Strategic Choices

Despite its advantages, the plasma pharmacological method is not without limitations, primarily concerning the use of anticoagulants:

  • EDTA: Can interfere with calcium-dependent biological reactions.
  • Heparin: Known to inhibit Taq polymerase in PCR and interfere with certain immunoassays.
  • Hirudin: A specific thrombin inhibitor that may be more suitable but requires careful experimental design.

Conclusion

While the serum pharmacological method has been the historical standard, the evidence suggests it creates a "serum-unique milieu" that deviates from the in vivo state. The plasma pharmacological method offers a more faithful representation of the physiological environment and the true state of absorbed herbal components. Researchers should prioritize the plasma method unless specific experimental constraints, such as anticoagulant interference, necessitate the use of serum. In cases of uncertainty, running both methods in parallel remains the most robust approach to ensuring scientific validity.

Summary updated

Abstract

Serum pharmacological method has generally been used in herb studies. However, preparation of test serum for ex vivo experiment is an intricate process: besides pretreatment (heat or chemicals), it involves the proteolytic cascades of coagulation along with fibrinolysis, complement and kinin systems, as well as platelet and leukocyte activation resulting in release reactions. These processes deviate serum sample components away from the original in vivo state, and possibly also have effects on the absorbed herbal components and their downstream effectors in blood. The conclusions drawn from serum pharmacological method are at least partially uncertain in its validity. These processes can be avoided by anticoagulation. Compared to those of the serum, constituents of plasma are better reflectors of the in vivo physiological/pathological state and medicinal herb-induced changes. Therefore, we have advocated the adoption of plasma pharmacological method in ex vivo experiments of herb studies. Recent studies including our work demonstrated that the constituents and biological activities are partially different between absorbed medicinal herbs in plasma and serum. This review summarizes the experimental evidence supporting the feasibility of plasma pharmacological method and discusses the reasons and facts that flaw the serum pharmacological method. But serum pharmacological method can be used if anticoagulants interfere with experiments. It should be emphasized that the domination between plasma and serum pharmacological methods is different depending on the usage. Indeed, the pros and cons of both methods as well as the appropriate choices of coagulants in different ex vivo experimental settings remain to be further elucidated.
BibTeX
@inproceedings{jinwen2010medicinal,
  author = {GE Jin-wen and Dongsheng Wang and Rong He and Huibin Zhu and Yuhong Wang and Shilin He},
  title = {{Medicinal Herb Research: Serum Pharmacological Method and Plasma Pharmacological Method}},
  booktitle = {Biological},
  year = {2010},
  doi = {10.1248/bpb.33.1459},
}
Figure